Li Yan, Du Yu-Feng, Gao Feng, Xu Jin-Bu, Zheng Ling-Li, Liu Gang, Lei Yu
Department of Pharmacy, The First Afflicted Hospital of Chengdu Medical College, Chengdu, China.
School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.
Front Pharmacol. 2022 Aug 11;13:968061. doi: 10.3389/fphar.2022.968061. eCollection 2022.
Microtubules are the fundamental part of the cell cytoskeleton intimately involving in cell proliferation and are superb targets in clinical cancer therapy today. Microtubule stabilizers have become one of the effectively main agents in the last decades for the treatment of diverse cancers. Taccalonolides, the highly oxygenated pentacyclic steroids isolated from the genus of , are considered a class of novel microtubule-stabilizing agents. Taccalonolides not only possess a similar microtubule-stabilizing activity as the famous drug paclitaxel but also reverse the multi-drug resistance of paclitaxel and epothilone in cellular and animal models. Taccalonolides have captured numerous attention in the field of medicinal chemistry due to their variety of structures, unique mechanism of action, and low toxicity. This review focuses on the structural diversity, semi-synthesis, modification, and pharmacological activities of taccalonolides, providing bright thoughts for the discovery of microtubule-stabilizing drugs.
微管是细胞骨架的基本组成部分,与细胞增殖密切相关,是当今临床癌症治疗的理想靶点。微管稳定剂在过去几十年中已成为治疗多种癌症的有效主要药物之一。从[具体属名]中分离出的高度氧化的五环甾体类化合物他卡诺内酯,被认为是一类新型微管稳定剂。他卡诺内酯不仅具有与著名药物紫杉醇相似的微管稳定活性,还能在细胞和动物模型中逆转紫杉醇和埃坡霉素的多药耐药性。由于其多样的结构、独特的作用机制和低毒性,他卡诺内酯在药物化学领域引起了广泛关注。本综述聚焦于他卡诺内酯的结构多样性、半合成、修饰及药理活性,为微管稳定药物的发现提供思路。